CUBIST PHARMACEUTICALS INC Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31)
CUBIST PHARMACEUTICALS INC reported Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) of $164.54 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsFutureAmortizationExpense · last filed 2012-08-07
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$5.22M.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $169.76M.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $163.03M.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$630.00K.
- CUBIST PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for fiscal 2011 was $174.98M.
| Period end | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 3 month | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 6 month | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 9 month | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $164.54M 10-Q · filed 2012-08-07 | $327.58M derived: sum of 3 quarters · filed 2012-08-07 | $326.95M derived: sum of 4 quarters · filed 2012-08-07 |
| 2012-03-31 | $169.76M 10-Q · filed 2012-05-01 | $332.79M derived: sum of 2 quarters · filed 2012-05-01 | $332.16M derived: sum of 3 quarters · filed 2012-05-01 | |
| 2011-12-31 | $163.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $162.40M derived: sum of 2 quarters · filed 2012-02-27 | $174.98M 10-K · filed 2012-02-27 | |
| 2011-09-30 | -$630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $11.95M 10-Q · filed 2011-11-02 | ||
| 2011-06-30 | $12.58M 10-Q · filed 2011-07-29 |